The Relationship Between Glucagon and Prostaglandin F in Stimulating Canine Hepatic Bile Flow

Abstract
Both glucagon and prostaglandin F have been shown to stimulate a chloride–rich choleresis in dogs. This study was performed to ascertain the interrelationship between glucagon and prostaglandin F in stimulating bile flow. The experiments were performed using dogs with chronic biliary and gastric fistulas. Initially, the effects of prostaglandin F on serum glucagon levels were evaluated. Glucagon administration increased bile volume andchloride secretion as did prostaglandin F. Serum glucagon levels during prostaglandin F administration were increased significantly over baseline values. During prostaglandin F administration, the increase in serum glucagon concentration correlated well with the increase in hepatic bile flow. Administration of somatostatin, a hormone known to inhibit glucagon release, prevented the choleresis produced by prostaglandin F while simultaneously eliminating the hyperglucagonemia. Subsequently, the effects of glucagon on bile prostaglandin F secretion and the effect of prostaglandin synthetase inhibition on glucagon choleresis were evaluated. Bile prostaglandin F secretion increased from control values of 101 ± 27 pg per min (mean ± S.D.) during bile salt infusion alone to 1,498 ± 1,086 pg per min during the administration of 1 μg kg-1 hr-1 glucagon. The prostaglandin synthetase inhibitor, indomethacin, significantly decreased the choleresis, the increased bile chloride secretion and the increased bile prostaglandin F secretion produced by glucagon. The results of this study indicate that prostaglandin F-stimulated bile flow is primarily the result of glucagon release and suggest that prostaglandin F may be involved in glucagon secretion. The inhibition of glucagon choleresis by indomethacin is compatible with the hypothesis that prostaglandin F partially mediates the response of the hormone associated with increased chloride secretion. Prostaglandin F may be involved in glucagon choleresis both during release of the hormone and at the site of its action.